VC Exec Talks M&A And 2024 Expectations

Insights from TVM’s Hubert Birner

VC Playbook: Hubert Birner, managing partner for Montreal and Munich, is responsible for TVM Capital Life Science’s overall investment approach and global fund operations. At the November 2023 BIO-Europe conference, he sat down with In Vivo to discuss the VC’s strategy and expectations for the European life science sector in 2024.  

TVM Capital Life Sciences is a transatlantic venture firm based in Munich, Germany. Hubert Birner, co-owner and managing partner at TVM, told In Vivo there was still a long way to go for the biotech sector in Europe compared to the US, but that “there's a lot of opportunity out there.”

TVM has a two-pronged strategy. First the firm is focused on early-stage companies, which are often one asset biotechs in...

More from VC Playbook

More from Growth